A091902: A Multicenter Phase II Trial of Paclitaxel with and without Nivolumab in Taxane Naive, and Nivolumab and Cabozantinib in Taxane Pretreated Subjects with Angiosarcoma
Aims: The purpose of this study is to see the good and bad effects of adding Nivolumab immunotherapy to Taxol chemotherapy.
Diagnosis: angio-sarcoma
Principal Investigator: Bruce Brockstein, MD
IRB Approval Number: EH20-414
Sponsor: Alliance for Clinical Trials in Oncology
Contact: Interested patients should contact research nurse Michele Britto, RN at 847.570.2109
Open to Enrollment: Yes
Ayala AL-DES-01: A Phase 2/3, Randomized, Multicenter Study to Evaluate AL 102 in Paitents iwth Progressing Desmoid Tumors
Aims: The purpose of this study is to see the good and bad effects of using the investigational drug called AL102 to treat desmoid tumors.
Diagnosis: Desmoid tumors
Principal Investigator: Bruce Brockstein, MD
IRB Approval Number: EH21-180
Sponsor: Ayala Pharmaceuticals, Inc.
Contact: Interested patients should contact research nurse Michele Britto, RN at 847.570.2109
Open to Enrollment: Yes